A Commitment Device for Medication Adherence Among HIV Patients

DATE: September 1, 2010 to August 31, 2014

The goal of this pilot was to assess whether a commitment contract informed by behavioral economics leads to persistent virologic suppression among HIV-positive patients with poor antiretroviral therapy (ART) adherence. We also assessed whether a commitment contract informed by behavioral economics leads to persistent virologic suppression among HIV-positive patients with poor antiretroviral therapy (ART) adherence. We found that commitment contracts can improve ART adherence and virologic suppression.

Investigator

David Laibson
David Laibson, Principal Investigator

Supported by the National Institute on Aging grant #P30AG034532

Related

Programs

Economics of Aging

More from NBER

In addition to working papers, the NBER disseminates affiliates’ latest findings through a range of free periodicals — the NBER Reporter, the NBER Digest, the Bulletin on Retirement and Disability, the Bulletin on Health, and the Bulletin on Entrepreneurship — as well as online conference reports, video lectures, and interviews.

Gita Gopinath The 2022 Martin Feldstein Lecture: Managing a Turn in the Global Financial Cycle Primary tabs
The 2022 Martin Feldstein Lecture: Managing a Turn in the Global Financial Cycle
  • Lecture
Gita Gopinath, the first deputy managing director of the International Monetary Fund, delivered the 2022 Martin...
2022 Summer Institute Methods Lectures: Empirical Bayes Methods, Theory and Application image
2022 Summer Institute Methods Lectures: Empirical Bayes Methods, Theory and Application
  • Lecture
Large data sets that include observations on many workers at a given firm, multiple decisions by individual judges,...
Ben Bernanke, Douglas Diamond, and Philip Dybvig
2022 Nobel Prize Celebrates Banking Research
  • Article
Former NBER research associate Ben Bernanke, current research associate Douglas Diamond, and Philip Dybvig have been awarded the 2022 Nobel Memorial...